市場調査レポート

商品コード

1441272

ヌクレオチドの世界市場規模、シェア、成長分析、タイプ別、用途別 - 産業別予測2023～2030年

Global Nucleotide Market Size, Share, Growth Analysis, By Type(Food Grade, Lab Grade), By Application(Pharmaceuticals, Food & beverage additive) - Industry Forecast 2023-2030

出版日: 2024年02月18日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のヌクレオチドの市場規模は、2022年に5億9,572万米ドルとなり、2023年の6億3,146万米ドルから、2031年までには10億646万米ドルに成長し、予測期間中（2024～2031年）のCAGRは6％で成長する見通しです。

世界的には、医薬品、食品・飲料、飼料、診断研究など様々な分野でヌクレオチドの利用が急増しており、市場拡大の原動力となっています。特定の香味料の欠点に関する消費者の意識の高まりが、ヌクレオチドベースの香味料に対する需要を促進し、それによって成長を刺激しています。特に注目すべきは、特に米国やカナダのような地域で、医薬品へのヌクレオチドの応用がエスカレートしていることであり、これは業界の拡大にプラスの影響を与えています。さらに、動物の健康懸念による畜産分野での世界の需要の急増が、ヌクレオチドベースの食品添加物に対するニーズを促進しています。さらに、診断研究におけるヌクレオチドの役割が拡大し、病気の検出や様々なウイルス感染症や特定のがんの検査が容易になったことで、当面の需要がさらに高まると予想されます。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

ヌクレオチドの世界市場：タイプ別

市場概要
食品グレード
ラボグレード
業界グレード

ヌクレオチドの世界市場：用途別

市場概要
医薬品
食品・飲料添加物
動物飼料添加物
その他

ヌクレオチドの世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Thermo Fisher Scientific（US）
Merck KGaA（Germany）
Roche（Switzerland）
Agilent Technologies（US）
New England BioLabs（US）
Takara Bio（Japan）
Bio-Rad Laboratories（US）
Lonza Group（Switzerland）
Promega Corporation（US）
QIAGEN（Germany）
Creative BioMart（China）
Bioss（China）
GenScript（China）
BioVision（US）
Eurofins Scientific（France）
Enzo Biochem（US）
SERVA Electrophoresis（Germany）
IDT（US）
Life Technologies（US）
Sigma-Aldrich（US）

Product Code: SQMIG15B2089

Global Nucleotide Market size was valued at USD 595.72 million in 2022 and is poised to grow from USD 631.46 million in 2023 to USD 1006.46 million by 2031, growing at a CAGR of 6% during the forecast period (2024-2031).

Globally, the burgeoning utilization of nucleotides across various sectors such as pharmaceuticals, food and beverage, animal feed, and diagnostic research is set to drive market expansion. Increased consumer awareness regarding the drawbacks of certain flavoring agents is propelling the demand for nucleotide-based flavor enhancers, thereby stimulating growth. Particularly notable is the escalating application of nucleotides in pharmaceuticals, notably in regions like the U.S. and Canada, which is positively impacting industry expansion. Moreover, the global surge in demand within the livestock sector due to animal health concerns is driving the need for nucleotide-based food additives. Additionally, the expanding role of nucleotides in diagnostic research, facilitating disease detection and testing for various viral infections or specific cancers, is expected to further fuel demand in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nucleotide Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nucleotide Market Segmental Analysis

The global nucleotide market is segmented on the basis of type, application, region. By type, the market is segmented into food grade, lab grade, industry grade. By application, the market is segmented into pharmaceuticals, food & beverage additive, animal feed additive, diagnostics research. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Nucleotide Market

The ongoing progress in pharmaceutical research and development drives the global nucleotide market forward, as nucleotides prove indispensable in various facets such as drug discovery, gene therapies, and personalized medicine. This essential role within the pharmaceutical industry fuels the increasing demand for nucleotides worldwide.

Restraints in the Global Nucleotide Market

Despite increasing awareness, a significant portion of consumers remain uninformed about nucleotides and their beneficial impacts. The potential for market growth could be hindered by this lack of comprehension, particularly in regions where the consumption of functional foods is not widespread.

Market Trends of the Global Nucleotide Market

The increasing consumer inclination towards natural and clean-label ingredients has spurred a growing demand for nucleotides sourced from natural origins, prompting manufacturers to prioritize sustainable and organic sourcing practices in response to this trend.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Nucleotide Market by Type

Market Overview
Food Grade
Lab Grade
and Industry Grade

Global Nucleotide Market by Application

Market Overview
Pharmaceuticals
Food & beverage additive
Animal feed additive
and Others

Global Nucleotide Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England BioLabs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative BioMart (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioss (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioVision (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SERVA Electrophoresis (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDT (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Life Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments